Laddar...
A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures
In a prior report, we showed that extended-release guanfacine (GEXR) is safe and effective for children with autism spectrum disorder (ASD) accompanied by ADHD symptoms. Here, we examine the impact of GEXR on oppositional behavior, anxiety, repetitive behavior, and sleep disturbance. Sixty-two subje...
Sparad:
| I publikationen: | Neuropsychopharmacology |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006142/ https://ncbi.nlm.nih.gov/pubmed/29540864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-018-0039-3 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|